Discover the transformative potential of GLP-1 drugs in healthcare revenue. With projections reaching $100 billion by 2030, the success of these pharmaceuticals not only benefits the industry giants but opens an unprecedented opportunity for healthcare providers.
In today's rapidly evolving healthcare landscape, the digital front door has opened up new possibilities for patient activation, fostering active patient participation and ultimately improving outcomes.
The other day, my professional and personal lives collided when I had a routine doctor's appointment. You know the drill: They call your name, you go back, get weighed (ugh),...
Meaningful use stage 2 sets the bar of 5% portal access for patient engagement and stage 3 raises the bar to 25%. What does it take to drive the adoption curve? There are multiple factors that help the adoption curve to take off. The three key factors that are very important are: 1. Access: […]
This year marks the 50th anniversary of the first Surgeon General’s report on the health hazards of smoking. While we are encouraged by the significant progress we have made in reducing the percentage of smokers from 43% to 18% in the past 50 years, the cost impact of smoking continues to ride high. According to […]
